formaldehyde has been researched along with Central Nervous System Neoplasm in 2 studies
paraform: polymerized formaldehyde; RN given refers to parent cpd; used in root canal therapy
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braggio, E | 1 |
| McPhail, ER | 1 |
| Macon, W | 1 |
| Lopes, MB | 1 |
| Schiff, D | 1 |
| Law, M | 1 |
| Fink, S | 1 |
| Sprau, D | 1 |
| Giannini, C | 1 |
| Dogan, A | 1 |
| Fonseca, R | 1 |
| O'Neill, BP | 1 |
| Chang, CC | 1 |
| Kampalath, B | 1 |
| Schultz, C | 1 |
| Bunyi-Teopengco, E | 1 |
| Logan, B | 1 |
| Eshoa, C | 1 |
| Dincer, AP | 1 |
| Perkins, SL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Clinical Efficacy and Safety of IBER Salvage Treatment Followed by Ibrutinib Maintenance for Transplant-ineligible Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma (PCNSL): a Multicenter, Single-arm, Prospective Phase II Study[NCT04066920] | Phase 2 | 30 participants (Anticipated) | Interventional | 2019-10-01 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for formaldehyde and Central Nervous System Neoplasm
| Article | Year |
|---|---|
Primary central nervous system lymphomas: a validation study of array-based comparative genomic hybridization in formalin-fixed paraffin-embedded tumor specimens.
Topics: Aged; Central Nervous System Neoplasms; Chromosome Aberrations; Comparative Genomic Hybridization; D | 2011 |
Expression of p53, c-Myc, or Bcl-6 suggests a poor prognosis in primary central nervous system diffuse large B-cell lymphoma among immunocompetent individuals.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Central Nervous System Neoplasms; DNA-Binding Pro | 2003 |